Skandinaviska Enskilda Banken (SEB)’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,828,045
Closed -$192M 504
2025
Q4
$192M Buy
1,828,045
+97,573
+6% +$9.16M 0.77% 22
2025
Q3
$145M Sell
1,730,472
-97,269
-5% -$8.01M 0.58% 29
2025
Q2
$145M Sell
1,827,741
-93,149
-5% -$7.4M 0.63% 23
2025
Q1
$172M Buy
1,920,890
+59,386
+3% +$5.54M 0.85% 22
2024
Q4
$183M Sell
1,861,504
-433,865
-19% -$44.7M 0.83% 20
2024
Q3
$261M Sell
2,295,369
-134,215
-6% -$15.9M 1.2% 14
2024
Q2
$301M Sell
2,429,584
-116,994
-5% -$15.1M 1.44% 10
2024
Q1
$336M Buy
2,546,578
+506,918
+25% +$62.5M 1.64% 9
2023
Q4
$222M Buy
2,039,660
+79,578
+4% +$8.26M 1.29% 12
2023
Q3
$202M Sell
1,960,082
-299,048
-13% -$32.2M 1.32% 12
2023
Q2
$261M Buy
2,259,130
+389,402
+21% +$44.2M 1.71% 9
2023
Q1
$199M Sell
1,869,728
-99,663
-5% -$10.8M 1.39% 8
2022
Q4
$219M Buy
1,969,391
+199,608
+11% +$20.4M 1.64% 5
2022
Q3
$152M Buy
1,769,783
+362,934
+26% +$32.4M 1.18% 13
2022
Q2
$128M Buy
1,406,849
+62,654
+5% +$5.55M 0.94% 15
2022
Q1
$110M Buy
1,344,195
+179,244
+15% +$14.1M 0.65% 26
2021
Q4
$89.9M Buy
1,164,951
+518,657
+80% +$41.3M 0.46% 47
2021
Q3
$48.5M Sell
646,294
-821,862
-56% -$62.5M 0.27% 88
2021
Q2
$114M Sell
1,468,156
-712,945
-33% -$53M 0.7% 21
2021
Q1
$160M Sell
2,181,101
-959,685
-31% -$70.8M 1.06% 14
2020
Q4
$245M Buy
3,140,786
+149,419
+5% +$11.4M 1.69% 5
2020
Q3
$237M Buy
2,991,367
+443,394
+17% +$34.7M 1.73% 5
2020
Q2
$188M Sell
2,547,973
-557,749
-18% -$42M 1.52% 7
2020
Q1
$228M Buy
3,105,722
+237,958
+8% +$18.7M 2.31% 3
2019
Q4
$249M Buy
2,867,764
+144,199
+5% +$11.8M 1.96% 3
2019
Q3
$219M Buy
2,723,565
+963,141
+55% +$77.2M 1.85% 3
2019
Q2
$141M Sell
1,760,424
-125,666
-7% -$9.62M 1.21% 17
2019
Q1
$150M Buy
1,886,090
+275,879
+17% +$20.6M 1.37% 17
2018
Q4
$117M Sell
1,610,211
-80,967
-5% -$5.72M 1.05% 22
2018
Q3
$114M Sell
1,691,178
-64,766
-4% -$4.13M 0.87% 29
2018
Q2
$102M Buy
1,755,944
+117,081
+7% +$6.61M 0.87% 28
2018
Q1
$85.2M Buy
1,638,863
+914,032
+126% +$49.4M 0.82% 31
2017
Q4
$38.9M Buy
724,831
+4,029
+0.6% +$223K 0.33% 72
2017
Q3
$44M Buy
720,802
+17,397
+2% +$1.05M 0.4% 63
2017
Q2
$43M Sell
703,405
-4,883
-0.7% -$297K 0.41% 60
2017
Q1
$42.9M Sell
708,288
-1,976
-0.3% -$120K 0.43% 53
2016
Q4
$39.9M Buy
710,264
+8,470
+1% +$496K 0.48% 45
2016
Q3
$41.8M Buy
701,794
+60,827
+9% +$3.56M 0.45% 45
2016
Q2
$35.2M Buy
640,967
+28,778
+5% +$1.53M 0.39% 56
2016
Q1
$30.9M Sell
612,189
-4,575
-0.7% -$224K 0.35% 60
2015
Q4
$31.1M Buy
+616,764
New +$31.1M 0.4% 51

Other funds holding MRK

Skandinaviska Enskilda Banken (SEB)'s MRK Position: Q1 2026 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Merck (MRK) in Q1 2026, closing a stake of 1,828,045 shares — an estimated $192M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in MRK in Q4 2015 and held it in 41 quarters. The position peaked at $336M in Q1 2024. 3,788 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 1,828,045 Merck shares in Q1 2026, an estimated $192M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Merck in Q4 2015 and held it in 41 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Merck position peaked at $336M in Q1 2024.
  • 3,788 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.